Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, December 30, 2009, 3:51AM ET - U.S. Markets open in 5 hours and 39 minutes. Dow Down 0.02% Nasdaq  0.00%
Unigene Laboratories Inc. (UGNE.OB)On Dec 29: 0.72   0.00 (0.00%)  
MORE ON UGNE.OB
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Wed, Dec 23, 2009
Unigene Files Shelf Registration Statement
Business Wire (Wed, Dec 23)
Thu, Dec 17, 2009
Unigene Announces Promising Preclinical Results in Its Obesity Peptide Program
Business Wire (Thu, Dec 17)
Mon, Dec 14, 2009
Biotech's Latest Failed Trials, Missed Targets
at Seeking Alpha (Mon, Dec 14)
Fri, Dec 11, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statements
EDGAR Online (Fri, Dec 11)
Thu, Dec 10, 2009
Independent Advisory Committee Recommends Continuation of Phase III Oral Calcitonin Studies for Osteoporosis and Osteoarthritis
Business Wire (Thu, Dec 10)
Wed, Dec 9, 2009
Unigene Announces Significant Cost Savings and Corporate Restructuring
Business Wire (Wed, Dec 9)
Fri, Nov 13, 2009
UNIGENE LABORATORIES INC Financials
EDGAR Online Financials (Fri, Nov 13)
Mon, Nov 9, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Mon, Nov 9)
Unigene Announces Financial Results for Third Quarter 2009
Business Wire (Mon, Nov 9)
Q3 2009 Unigene Laboratories, Inc. Earnings Release - After Market Close
CCBN (Mon, Nov 9)
Wed, Nov 4, 2009
Unigene to Release Third Quarter 2009 Results and Host Conference Call
Business Wire (Wed, Nov 4)
Tue, Oct 20, 2009
Unigene to Host Conference Call to Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics
Business Wire (Tue, Oct 20)
UNIGENE LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
EDGAR Online (Tue, Oct 20)
Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics
Business Wire (Tue, Oct 20)
Mon, Aug 10, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Mon, Aug 10)
UNIGENE LABORATORIES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Aug 10)
Fri, May 29, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-
EDGAR Online (Fri, May 29)
Mon, May 11, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, May 11)
Mon, Mar 16, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Mar 16)
Fri, Feb 6, 2009
UNIGENE LABORATORIES INC Files SEC form 8-K/A, Change in Directors or Principal Officers
EDGAR Online (Fri, Feb 6)
Older Headlines - Download Recent Headlines
View headlines from:
Add UGNE.OB News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage